title: Streptobacillus moniliformis epizootic in barrier-maintained C57BL/6J mice and susceptibility to infection of different strains of mice.
abstract: We report a Streptobacillus moniliformis epizootic in barrier-maintained SPF mice. Although various inbred and F1 hybrid strains of mice have been kept in this animal facility, only C57BL/6J Han [corrected] mice showed clinical signs of disease. During the course of the epizootic, 825 breeding animals (approximately 36% of the breeders) died or had to be killed because of severe clinical signs. Although sequential treatment with ampicillin and chlortetracycline gave good therapeutic results, the animal facility was vacated in order to exclude any risk of cross-contamination of the other rodent colonies in our institute. The source and route of transmission of S. moniliformis could not be elucidated. To investigate strain dependent differences experimental infection of different strains of mice with our S. moniliformis isolate was performed. After oral infection only C57BL/6J showed the typical signs of a cervical lymphadenitis and gave an immunological response. BALB/cJ, C3H/He, DBA/2J, CB6F1 and B6D2F1 mice were not affected except in two cases of DBA/2J and B6D2F1 mice where seroconversion was observed. After intravenous infection of C57BL/6J, DBA/2J [corrected] and BALB/cJ all animals showed positive titers in the indirect immunofluorescence test (IIF). One hundred percent of the C57BL/6J, forty percent of the DBA/2J, and none of the BALB/cJ mice developed severe symptoms. The results demonstrate that the susceptibility to streptobacillosis is predominantly influenced by genetic factors.
authors.affiliation: Central Institute for Laboratory Animal Breeding, Hannover, F.R.G.
authors.forename: M
authors.initials: M
authors.lastname: Wullenweber
authors.forename: J
authors.initials: J
authors.lastname: Kaspareit-Rittinghausen
authors.forename: M
authors.initials: M
authors.lastname: Farouq
mesh_terms: D000667:Ampicillin / Q000627:therapeutic use; D000822:Animal Husbandry; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000662:veterinary*; D002751:Chlortetracycline / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000662:veterinary*; D004196:Disease Outbreaks / Q000662:veterinary*; D005260:Female; D051379:Mice; D008810:Mice, Inbred C57BL; D013288:Streptobacillus / Q000302:isolation & purification / Q000472:pathogenicity*
chemical_list: D000667:Ampicillin; D002751:Chlortetracycline